Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Strategies to Overcome Residual Risk During Statins Era
Kyoung Im Cho, Jongwook Yu, Toshio Hayashi, et al.
Circulation Journal (2019) Vol. 83, Iss. 10, pp. 1973-1979
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and recommendations for improved effectiveness
Michael E. Makover, Michael D. Shapiro, Peter P. Tóth
American Journal of Preventive Cardiology (2022) Vol. 12, pp. 100371-100371
Open Access | Times Cited: 59
The Potential Cardiometabolic Effects of Long-Chain ω-3 Polyunsaturated Fatty Acids: Recent Updates and Controversies
Jae Hyun Bae, Hyunjung Lim, Soo Lim
Advances in Nutrition (2023) Vol. 14, Iss. 4, pp. 612-628
Open Access | Times Cited: 36
Triglyceride-Rich Lipoprotein Metabolism: Key Regulators of Their Flux
Alejandro Gugliucci
Journal of Clinical Medicine (2023) Vol. 12, Iss. 13, pp. 4399-4399
Open Access | Times Cited: 28
Lipoprotein(a) and Cardiovascular Diseases ― Revisited ―
Albert Youngwoo Jang, Seung Hwan Han, Il Suk Sohn, et al.
Circulation Journal (2020) Vol. 84, Iss. 6, pp. 867-874
Open Access | Times Cited: 66
Cardiovascular effects of omega-3 fatty acids: Hope or hype?
Sang‐Ho Jo, Seung Hwan Han, Sang‐Hyun Kim, et al.
Atherosclerosis (2021) Vol. 322, pp. 15-23
Closed Access | Times Cited: 27
Synergistic effect of the commonest residual risk factors, remnant cholesterol, lipoprotein(a), and inflammation, on prognosis of statin-treated patients with chronic coronary syndrome
Huihui Liu, Yuan-Lin Guo, Cheng‐Gang Zhu, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 22
Lipoprotein(a), Immune Cells and Cardiovascular Outcomes in Patients with Premature Coronary Heart Disease
O. Afanasieva, A. V. Tyurina, E. Klesareva, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 2, pp. 269-269
Open Access | Times Cited: 19
Effect of PCSK9 Inhibitor on Blood Lipid Levels in Patients with High and Very-High CVD Risk: A Systematic Review and Meta-Analysis
Yue Zhang, Yanrong Suo, Lin Yang, et al.
Cardiology Research and Practice (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 18
Adiponectin and cardiometabolic trait and mortality: where do we go?
Albert Youngwoo Jang, Philipp E. Scherer, Jang‐Young Kim, et al.
Cardiovascular Research (2021) Vol. 118, Iss. 9, pp. 2074-2084
Closed Access | Times Cited: 23
Sphingolipid Profiling: A Promising Tool for Stratifying the Metabolic Syndrome-Associated Risk
Loni Berkowitz, Fernanda Cabrera-Reyes, Cristián Salazar, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 8
Open Access | Times Cited: 15
Angiopoietin-like Proteins and Lipoprotein Lipase: The Waltz Partners That Govern Triglyceride-Rich Lipoprotein Metabolism? Impact on Atherogenesis, Dietary Interventions, and Emerging Therapies
Alejandro Gugliucci
Journal of Clinical Medicine (2024) Vol. 13, Iss. 17, pp. 5229-5229
Open Access | Times Cited: 2
New Trends in Dyslipidemia Treatment
Albert Youngwoo Jang, Soo Lim, Sang‐Ho Jo, et al.
Circulation Journal (2020) Vol. 85, Iss. 6, pp. 759-768
Open Access | Times Cited: 19
Accelerated Ovarian Aging Among Type 2 Diabetes Patients and Its Association With Adverse Lipid Profile
Yahao Wang, Yangang Wang
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 11
Fasting and Non-Fasting Triglycerides and Risk of Cardiovascular Events in Diabetic Patients Under Statin Therapy
Hayato Tada, Akihiro Nomura, Kenichi Yoshimura, et al.
Circulation Journal (2020) Vol. 84, Iss. 3, pp. 509-515
Open Access | Times Cited: 17
Effect of an increase in Lp(a) following statin therapy on cardiovascular prognosis in secondary prevention population of coronary artery disease
Lijun Zhu, Yangliang Fang, Beibei Gao, et al.
BMC Cardiovascular Disorders (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 9
HDL-associated apoCIII plays an independent role in predicting postprandial hypertriglyceridemia
Tianhua Zhang, Xiaoyu Tang, Ling Mao, et al.
Clinical Biochemistry (2020) Vol. 79, pp. 14-22
Closed Access | Times Cited: 13
Combined effect of D-dimer, hs-CRP, and Lp(a) on 5-year clinical outcomes after percutaneous coronary intervention: A large real-world study in China
Jiawen Li, Pei Zhu, Xiaofang Tang, et al.
iScience (2023) Vol. 26, Iss. 7, pp. 107030-107030
Open Access | Times Cited: 4
Lipoprotein(a) and Cardiovascular Outcomes after Revascularization of Carotid and Lower Limbs Arteries
М. В. Ежов, N. A. Tmoyan, O. Afanasieva, et al.
Biomolecules (2021) Vol. 11, Iss. 2, pp. 257-257
Open Access | Times Cited: 10
A Meta-Analysis Evaluating the Colchicine Therapy in Patients With Coronary Artery Disease
Stefan Grajek, Michał Michalak, Tomasz Urbanowicz, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 10
Sugar and Dyslipidemia: A Double-Hit, Perfect Storm
Alejandro Gugliucci
Journal of Clinical Medicine (2023) Vol. 12, Iss. 17, pp. 5660-5660
Open Access | Times Cited: 3
Comorbidities Associated With Residual Cardiovascular Risk in Patients With Chronic Coronary Syndrome Receiving Statin Therapy ― Subanalysis of the REAL-CAD Trial ―
Kohei Wakabayashi, Hiroshi Suzuki, Yoshihiro Fukumoto, et al.
Circulation Reports (2022) Vol. 4, Iss. 9, pp. 422-428
Open Access | Times Cited: 5
Optimization of the MACE endpoint composition to increase power in studies of lipid-lowering therapies—a model-based meta-analysis
Alina Volkova, Б. В. Шульгин, Gabriel Helmlinger, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 10
Open Access
Fish Oil Supplements for Prevention of Cardiovascular Disease: The Jury Is Still Out: CON: Fish Oil is Useful to Prevent or Treat Cardiovascular Disease.
Hekmat B. Khoukaz, William P. Fay
PubMed (2021) Vol. 118, Iss. 3, pp. 219-225
Closed Access | Times Cited: 3
Usefulness of Novel Atherogenic Lipid Indices for The Evaluation of Metabolic Status Leading to Coronary Heart Disease in A Real-World Survey of The Japanese Population
Isamu Matsunaga, Miyuki Ando, Yuki Tsubakimoto, et al.
(2022)
Open Access | Times Cited: 1
Effect of an increase in Lp(a) following statin therapy on cardiovascular prognosis in secondary prevention population of coronary artery disease
Lijun Zhu, Yangliang Fang, Beibei Gao, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top